ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.254,18
1,03%
S&P 500
5.473,17
-0,25%
Dow Jones
39.134,76
0,77%
Euro vs US Dollar
1,07165
0,09%
Bitcoin
64.610,43
-0,32%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Korro Bio Inc (KRRO)

  7. Korro Bio Inc (KRRO) News

KRRO Korro Bio Inc

35,89
2,28 (6,78%)
20 Jun 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Korro Bio Inc KRRO NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
2,28 6,78% 35,89 22:12:36
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
33,10 33,10 35,97 35,89 33,61
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
17.6.202422:27EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
17.6.202422:22EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
12.6.202423:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.6.202423:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.6.202422:05EDGAR2Form 8-K - Current report
05.6.202401:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30.5.202422:01GLOBEKorro to Participate in Upcoming June Investor and..
23.5.202406:15EDGAR2Form EFFECT - Notice of Effectiveness
22.5.202422:37EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
20.5.202420:30GLOBEKorro Presents Additional Preclinical Data for KRRO-110 at..
15.5.202402:22EDGAR2Form 3 - Initial statement of beneficial ownership of..
14.5.202422:34EDGAR2Form S-1 - General form for registration of securities under..
14.5.202422:20EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
14.5.202422:03EDGAR2Form 8-K - Current report
14.5.202422:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14.5.202422:02EDGAR2Form 8-K - Current report
14.5.202422:01GLOBEKorro Reports First Quarter 2024 Financial Results and..
18.4.202414:30GLOBEKorro Announces $70 Million Private Placement
01.4.202422:01GLOBEKorro to Participate in Upcoming Investor Conferences
26.3.202421:01GLOBEKorro Reports Full Year 2023 Financial Results and..
27.2.202414:00GLOBEKorro to Present at the TD Cowen 44th Annual Health Care..
18.1.202414:00GLOBEKorro Bio Highlights Data for its Lead Program in Alpha-1..
09.1.202415:02EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
09.1.202415:00EDGAR2Form 8-K - Current report
04.1.202414:00GLOBEKorro to Present at the 42nd Annual J.P. Morgan Healthcare..
22.12.202322:31EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
20.12.202322:44EDGAR2Form S-1/A - General form for registration of securities..
07.12.202314:00GLOBEKorro Announces Selection of its First Development Candidate..
01.12.202322:07EDGAR2Form S-1/A - General form for registration of securities..
29.11.202322:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.11.202322:53EDGAR2Form 3 - Initial statement of beneficial ownership of..
29.11.202322:01EDGAR2Form 8-K - Current report
28.11.202314:00GLOBEKorro Bio Appoints Dr. Rachel Meyers to Board of Directors
28.11.202302:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.11.202322:19EDGAR2Form 144 - Report of proposed sale of securities
22.11.202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.11.202321:25EDGAR2Form 144 - Report of proposed sale of securities
17.11.202322:23EDGAR2Form SC 13G - Statement of acquisition of beneficial..
17.11.202318:38EDGAR2Form SC 13D - General statement of acquisition of beneficial..
13.11.202322:15EDGAR2Form SC 13D - General statement of acquisition of beneficial..
13.11.202315:35EDGAR2Form 144 - Report of proposed sale of securities
13.11.202314:58EDGAR2Form 144 - Report of proposed sale of securities
13.11.202313:51EDGAR2Form 144 - Report of proposed sale of securities
08.11.202303:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.11.202303:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.11.202303:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.11.202303:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.11.202303:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.11.202303:05EDGAR2Form 3 - Initial statement of beneficial ownership of..
08.11.202303:02EDGAR2Form 3 - Initial statement of beneficial ownership of..

Kürzlich von Ihnen besucht

NASDAQ
KRRO
Korro Bio
COIN
BCFEUR
BIT
P1X9D9
NLBNPIT1X9D9 20991231 35...
LSE
0K1K
BOV
BHYG39
BlackRock Institutional ...
EU
3621T
3621T
USOTC
OVCHF
Overseas Chinese Bank (PK)
NYSE
ACEL
Accel Entertainment
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten